CLINICAL_TRIALS
ClinicalTrials.gov record update
Benralizumab Effect on Severe Chronic Rhinosinusitis With Eosinophilic Polyposis: A Phase II Randomized Placebo Controlled Trial
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03450083
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:37:49.508644+00:00
- Published At
- 2021-01-22T00:00:00+00:00
- Record Updated At
- 2021-02-11
- Results Posted At
- 2021-01-22
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Chronic Rhinosinusitis (Diagnosis)", "Nasal Polyps", "Eosinophilia"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-02-11"- protocolSection.identificationModule.nctId
"NCT03450083"- protocolSection.identificationModule.officialTitle
"Benralizumab Effect on Severe Chronic Rhinosinusitis With Eosinophilic Polyposis: A Phase II Randomized Placebo Controlled Trial"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2021-01-22"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.